Işık, A. Et Al. 2023. THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.61 .

Işık, A., Muhtaroğlu, S., & Akyol, G., (2023). THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.61.

Işık, AYŞE, SABAHATTİN MUHTAROĞLU, And Gülşah Akyol. "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA," CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.61, 2023

Işık, AYŞE Et Al. "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA." CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.61, 2023

Işık, A. Muhtaroğlu, S. And Akyol, G. (2023) . "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA." CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.61.

@article{article, author={AYŞE IŞIK Et Al. }, title={THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA}, journal={CLINICAL CHEMISTRY AND LABORATORY MEDICINE}, year=2023}